Market cap
$37 Mln
Market cap
$37 Mln
Revenue (TTM)
$23,475 Mln
P/E Ratio
--
P/B Ratio
3.8
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$-615 Mln
ROE
-26.3 %
ROCE
-- %
Industry P/E
21.73
EV/EBITDA
-17.2
Debt to Equity
0
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
56,696,300
CFO
$3,455.05 Mln
EBITDA
$6,826.69 Mln
Net Profit
$1,191.66 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Rite Aid (RAD)
| -94.8 | -37.2 | -75.0 | -96.1 | -78.9 | -60.5 | -47.6 |
|
BSE Sensex*
| -6.4 | 6.4 | -3.5 | 0.9 | 10.0 | 10.7 | 11.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|---|---|---|---|---|---|---|---|
|
Rite Aid (RAD)
| -77.3 | -7.2 | 2.3 | 9.2 | -63.8 | -76.1 | 5.1 |
|
S&P Small-Cap 600
| -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 | 24.7 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and... provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and seasonal merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. In addition, it offers its products through online retail site. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania. Read more
Pres, CEO & Director
Ms. Heyward Rutledge Donigan B.A.
CFO & Exec. VP
Mr. Matthew C. Schroeder
Headquarters
Philadelphia, PA
Website
The share price of Rite Aid Corporation (RAD) is $0.17 (NYSE) as of 15-Dec-2023 09:30 EDT. Rite Aid Corporation (RAD) has given a return of -78.92% in the last 3 years.
Since, TTM earnings of Rite Aid Corporation (RAD) is negative, P/E ratio is not available.
The P/B ratio of Rite Aid Corporation (RAD) is 3.77 times as on 15-Dec-2023, a 8 premium to its peers’ median range of 3.50 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2023
|
--
|
--
|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
The 52-week high and low of Rite Aid Corporation (RAD) are Rs -- and Rs -- as of 21-Apr-2026.
Rite Aid Corporation (RAD) has a market capitalisation of $ 37 Mln as on 15-Dec-2023. As per SEBI classification, it is a Small Cap company.
Before investing in Rite Aid Corporation (RAD), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.